Beckebaum S - Search Results

1

Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study.

Beckebaum S, Cicinnati VR, Zhang X, Malago M, Dirsch O, Erim Y, Frilling A, Broelsch CE, Gerken G. Beckebaum S, et al. Transplant Proc. 2004 Jun;36(5):1489-91. doi: 10.1016/j.transproceed.2004.05.017. Transplant Proc. 2004. PMID: 15251366 Clinical Trial.

2

Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.

Beckebaum S, Cicinnati VR, Karliova M, Dirsch O, Erim Y, Frilling A, Malago M, Broelsch CE, Treichel U, Gerken G. Beckebaum S, et al. Transplant Proc. 2003 Sep;35(6):2080-1. doi: 10.1016/s0041-1345(03)00681-x. Transplant Proc. 2003. PMID: 14529846 No abstract available.

3

Treatment of hepatitis B reinfection after liver transplantation.

Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE. Beckebaum S, et al. Minerva Chir. 2003 Oct;58(5):705-16. Minerva Chir. 2003. PMID: 14603149 Review.

4

Future directions in immunosuppression.

Beckebaum S, Cicinnati VR, Broelsch CE. Beckebaum S, et al. Transplant Proc. 2004 Mar;36(2 Suppl):574S-576S. doi: 10.1016/j.transproceed.2004.01.044. Transplant Proc. 2004. PMID: 15041408 Review.

5

Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study.

Beckebaum S, Cicinnati VR, Klein CG, Brokalaki E, Yu Z, Malago M, Frilling A, Gerken G, Broelsch CE. Beckebaum S, et al. Transplant Proc. 2004 Nov;36(9):2671-4. doi: 10.1016/j.transproceed.2004.10.008. Transplant Proc. 2004. PMID: 15621120 Clinical Trial.

6

[Advances and limitations of liver transplantation in Germany].

Beckebaum S, Cicinnati VR, Broelsch CE. Beckebaum S, et al. Verh Dtsch Ges Pathol. 2004;88:45-50. Verh Dtsch Ges Pathol. 2004. PMID: 16892533 German.

7

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation.

Cicinnati VR, Iacob S, Klein CG, Baba HA, Sotiropoulos GC, Hilgard P, Erim Y, Broelsch CE, Gerken G, Beckebaum S. Cicinnati VR, et al. Among authors: beckebaum s. Aliment Pharmacol Ther. 2007 Jul 15;26(2):291-303. doi: 10.1111/j.1365-2036.2007.03363.x. Aliment Pharmacol Ther. 2007. PMID: 17593075

8

Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.

Beckebaum S, Chen X, Sotiropoulos GC, Radtke A, Daoudaki M, Baba HA, Wohlschlaeger J, Broelsch CE, Gerken G, Cicinnati VR. Beckebaum S, et al. Transplant Proc. 2008 Nov;40(9):3182-4. doi: 10.1016/j.transproceed.2008.08.034. Transplant Proc. 2008. PMID: 19010227

9

Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study.

Beckebaum S, Klein CG, Sotiropoulos GC, Saner FH, Gerken G, Paul A, Cicinnati VR. Beckebaum S, et al. Transplant Proc. 2009 Jul-Aug;41(6):2567-9. doi: 10.1016/j.transproceed.2009.06.152. Transplant Proc. 2009. PMID: 19715976 Clinical Trial.

10

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation.

Beckebaum S, Malagó M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. Beckebaum S, et al. Clin Transplant. 2003 Dec;17(6):554-9. doi: 10.1046/j.0902-0063.2003.00097.x. Clin Transplant. 2003. PMID: 14756274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters